Across TCGA pan-cancer cohorts, SPINK14 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SPINK14 data layer compared with 17 for mass-spec protein.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher SPINK14 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SPINK14 expression acts as an unfavorable survival marker.
LUSC are the cancer types where SPINK14 Mutation most reproducibly stratifies survival.